معرفی
Luca Fava is an Associate Professor in the Department of Cellular, Computational, and Integrative Biology (CIBIO) at the University of Trento. He holds a PhD in Cell Biology from the Max Planck Institute of Biochemistry and University of Basel (2011), and has held academic positions at the University of Trento since 2017, including roles as Assistant Professor (2017–2020) and Associate Professor (2020–present). His research focuses on cell biology mechanisms, particularly centrosome integrity, DNA damage responses, and cancer biology. Key areas include apoptosis regulation, tumor suppression, and the interplay between cellular stress and genomic instability.
Dr. Fava’s teaching includes coordinating the BSc program in Biomolecular Sciences and Technology, alongside lecturing on Cell Biology, emphasizing molecular mechanisms, experimental techniques, and applications to human pathology. His work integrates genomic approaches, organoid models, and CRISPR-Cas9 technologies to study genetic disorders like Wolman disease and Cornelia de Lange Syndrome.
His research trends highlight centrosome surveillance pathways, p53 modulation in cancer, and drug repurposing strategies. Recent studies focus on mitotic checkpoint failures, inflammatory responses, and viral infection mechanisms (e.g., SARS-CoV-2). His lab employs cutting-edge proteomics and functional genomics to bridge fundamental biology with translational medicine.
No scientific awards were explicitly mentioned in the provided texts. His advising and grant activities are not detailed, though his publications indicate active collaborative research. Dr. Fava’s work contributes to understanding cellular processes with implications for cancer therapy and genetic disease modeling.
